Stay updated with breaking news from Advaxis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report released on Friday. The firm issued a sell rating on the stock. Ayala Pharmaceuticals Trading Down 2.3 % Shares of Ayala Pharmaceuticals stock opened at $1.04 on Friday. Ayala Pharmaceuticals has a one year low of $0.65 and a one […]
05:00/JPN: Apr Economy Watchers Survey 11:00/UK: Bank of England Monetary Policy Report 11:00/UK: UK interest rate decision 12:30/US: 05/06 Unemployment Insurance Weekly Claims Report - Initial Claims 12:30/US: Apr PPI 12:30/US: U.S... | 06:15am
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance NASDAQ:ADXS opened at $0.95 on Thursday. Ayala Pharmaceuticals has a 52 week low of $0.65 and a 52 week high of […]
The oil-and-gas giant generated adjusted earnings of $9.65 billion in the three months through the end of March, beating the market consensus of $7.965 billion, taken from Vara Research and...
StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report issued on Wednesday morning. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Stock Performance Ayala Pharmaceuticals stock opened at $1.15 on Wednesday. The stock has a market capitalization of $2.09 million, a PE ratio of -0.13 and […]